Delivery Order SPE2DB20D7066-SPE2DB25FC4QG
- Not listed
- The Defense Logistics Agency awarded a $30,338.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. The contract, which is scheduled for completion by August 7, 2025, represents a non-set-aside competitive award and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,954.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for $1,229.33 under a firm fixed-price contract. The order covers ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of September 9, 2025. This non-competitive delivery order was placed without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for ENGERIX-B 20 MCG/ML vaccine syringes with a ceiling value of $1,744.15. This is a firm fixed-price delivery order representing a competitive award with no set-aside designation. The order is set for ultimate completion by August 26, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,961.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a completion date of September 4, 2025. This non-competitive delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,920.10 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed price, competitively awarded contract was issued on September 2, 2025, with a completion date of September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,504.80 on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract covers the supply of ENGERIX-B 20 MCG/ML vaccine syringes under a firm fixed price arrangement. This is a non-set-aside award, meaning it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child...
- The Defense Logistics Agency awarded a $2,331.42 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,315.65 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with performance in Conshohocken, Pennsylvania. This firm fixed price, non-set-aside contract was competitively awarded and is scheduled for completion by August 15, 2025. The award represents a single delivery order transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes, with a contract value of $1,849.44 and a completion date of September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4QGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,284.58 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine syringes. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, was competitively awarded without a set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of the nation's largest pharmaceutical distributors and healthcare solutions providers. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's continued selection as a prime vendor for federal medical procurement reflects its established capability to meet government requirements for critical pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 9/5/25 |